NO914387L - Fremstilling av hemoglobin og dens analoger i bakterier og gjaer - Google Patents
Fremstilling av hemoglobin og dens analoger i bakterier og gjaerInfo
- Publication number
- NO914387L NO914387L NO91914387A NO914387A NO914387L NO 914387 L NO914387 L NO 914387L NO 91914387 A NO91914387 A NO 91914387A NO 914387 A NO914387 A NO 914387A NO 914387 L NO914387 L NO 914387L
- Authority
- NO
- Norway
- Prior art keywords
- hemoglobin
- polypeptide
- alpha
- analogs
- bacteria
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6445—Haemoglobin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Detergent Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34962389A | 1989-05-10 | 1989-05-10 | |
US37416189A | 1989-06-30 | 1989-06-30 | |
US37911689A | 1989-07-13 | 1989-07-13 | |
PCT/US1990/002654 WO1990013645A1 (en) | 1989-05-10 | 1990-05-10 | Production in bacteria and yeast of hemoglobin and analogues thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
NO914387D0 NO914387D0 (no) | 1991-11-08 |
NO914387L true NO914387L (no) | 1991-11-08 |
NO304027B1 NO304027B1 (no) | 1998-10-12 |
Family
ID=27407902
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO914387A NO304027B1 (no) | 1989-05-10 | 1991-11-08 | Fremstilling av hemoglobin og dens analoger i bakterier og gjµr |
NO19973848A NO315568B1 (no) | 1989-05-10 | 1997-08-21 | Fremgangsmåte til fremstilling av hemoglobinliknende protein |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19973848A NO315568B1 (no) | 1989-05-10 | 1997-08-21 | Fremgangsmåte til fremstilling av hemoglobinliknende protein |
Country Status (18)
Country | Link |
---|---|
EP (3) | EP1380645A2 (no) |
JP (1) | JP3013902B2 (no) |
KR (1) | KR920701434A (no) |
AT (2) | ATE142692T1 (no) |
AU (1) | AU635744B2 (no) |
CA (1) | CA2050601C (no) |
DE (2) | DE69034091T2 (no) |
DK (1) | DK0402300T3 (no) |
ES (2) | ES2204926T3 (no) |
FI (2) | FI105104B (no) |
GR (1) | GR3021106T3 (no) |
HU (1) | HUT61591A (no) |
IE (1) | IE970086A1 (no) |
IL (1) | IL94361A (no) |
NO (2) | NO304027B1 (no) |
NZ (1) | NZ233642A (no) |
SG (1) | SG47987A1 (no) |
WO (1) | WO1990013645A1 (no) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6022849A (en) * | 1987-05-16 | 2000-02-08 | Baxter Biotech Technology Saarl | Mutant recombinant hemoglobins containing heme pocket mutations |
US6204009B1 (en) | 1988-05-16 | 2001-03-20 | BAXTER BIOTECH TECHNOLOGY SàRL | Nucleic acids encoding mutant recombinant hemoglobins containing heme pocket mutations |
US6150506A (en) * | 1989-05-10 | 2000-11-21 | Baxter Biotech Technology Sarl | Modified hemoglobin-like compounds and methods of purifying same |
US5545727A (en) * | 1989-05-10 | 1996-08-13 | Somatogen, Inc. | DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin |
US5844090A (en) * | 1994-05-09 | 1998-12-01 | Somatogen, Inc. | Modified hemoglobin-like compounds |
US5599907A (en) * | 1989-05-10 | 1997-02-04 | Somatogen, Inc. | Production and use of multimeric hemoglobins |
WO1991013158A1 (en) * | 1990-02-28 | 1991-09-05 | Delta Biotechnology Limited | Protein production in yeast |
US6172039B1 (en) | 1990-04-16 | 2001-01-09 | Apex Bioscience, Inc. | Expression of recombinant hemoglobin and hemoglobin variants in yeast |
DE69133089T2 (de) * | 1990-04-16 | 2003-04-17 | Apex Bioscience, Inc. | Expression von rekombinantem hämoglobin in hefe |
US5610137A (en) * | 1990-12-20 | 1997-03-11 | The Uab Research Foundation | Transgenic, cross-linked hemoglobin |
EP0668909B1 (en) * | 1990-12-20 | 2001-10-10 | The University Of Alabama Research Foundation | Transgenic, cross-linked hemoglobin |
US5714345A (en) * | 1990-12-24 | 1998-02-03 | Pharmaceutical Proteins Limited | Increased expression of a gene by a second transferred mammary gland specific sequence transgenic |
GB9028062D0 (en) * | 1990-12-24 | 1991-02-13 | Agricultural & Food Res | Production of transgenic animals |
WO1993008831A1 (en) * | 1991-10-30 | 1993-05-13 | Strohtech, Inc. | Expression of recombinant hemoglobin and hemoglobin variants in yeast |
ATE168014T1 (de) * | 1991-11-08 | 1998-07-15 | Somatogen Inc | Hämoglobine als arzneimittelabgabesystem |
FR2688784B1 (fr) * | 1992-03-18 | 1995-06-30 | Pasteur Merieux Serums Vacc | Transporteur d'oxygene. |
US6610654B2 (en) | 1993-03-31 | 2003-08-26 | Wellstat Therapeutics Corporation | Inhibitor of stem cell proliferation and uses thereof |
US5939391A (en) * | 1993-03-31 | 1999-08-17 | Pro-Neuron, Inc. | Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
UA40613C2 (uk) * | 1993-03-31 | 2001-08-15 | Про-Нейрон, Інк. | Поліпептид, що має активність інгібітора проліферації стовбурових клітин(варіанти), фармацевтична композиція (варіанти), фармацевтична композиція для інгібування ділення стовбурових клітин у ссавців, фармацевтична композиція для лікування захворювань,які включають гіперпроліферативні стани, фармацевтична композиція для диференціального захисту нормальних стовбурових клітин, відмінних від лейкозних, спосіб очистки поліпептиду |
US5554638A (en) * | 1993-05-24 | 1996-09-10 | Duke University | Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
US5612310A (en) * | 1993-05-24 | 1997-03-18 | Duke University | Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
US5840851A (en) * | 1993-07-23 | 1998-11-24 | Plomer; J. Jeffrey | Purification of hemoglobin |
US5665869A (en) * | 1993-11-15 | 1997-09-09 | Somatogen, Inc. | Method for the rapid removal of protoporphyrin from protoporphyrin IX-containing solutions of hemoglobin |
US6140071A (en) * | 1994-01-27 | 2000-10-31 | Somatogen, Inc. | Proteins with mutations to decrease N-terminal methylation |
US5631219A (en) * | 1994-03-08 | 1997-05-20 | Somatogen, Inc. | Method of stimulating hematopoiesis with hemoglobin |
US6242417B1 (en) | 1994-03-08 | 2001-06-05 | Somatogen, Inc. | Stabilized compositions containing hemoglobin |
WO1997004110A1 (en) * | 1995-07-14 | 1997-02-06 | Somatogen, Inc. | Methods for increasing protein expression |
US5824511A (en) * | 1995-08-01 | 1998-10-20 | University Technology Corporation | Method for enhancing the production of hemoproteins |
US6812207B1 (en) | 1995-10-23 | 2004-11-02 | William Marsh Rice University | Hemoglobin mutants that reduce heme loss |
CA2231245A1 (en) * | 1995-10-23 | 1997-05-01 | Mark S. Hargrove | Hemoglobin mutants that reduce heme loss |
CA2236794A1 (en) * | 1995-11-30 | 1997-06-05 | Bruce A. Kerwin | Method for control of functionality during cross-linking of hemoglobins |
WO1997023631A2 (en) * | 1995-12-22 | 1997-07-03 | Somatogen, Inc. | Globins containing binding domains |
AU715914B2 (en) | 1995-12-22 | 2000-02-10 | Baxter Biotech Technology S.A.R.L. | Globins containing binding domains |
US5861483A (en) | 1996-04-03 | 1999-01-19 | Pro-Neuron, Inc. | Inhibitor of stem cell proliferation and uses thereof |
US6136565A (en) * | 1996-10-18 | 2000-10-24 | Baxter Biotech Technology Sarl | Methods of reducing the levels of protoporphyrin IX in recombinant hemoglobin preparations |
EP1950298A3 (en) | 1997-05-02 | 2008-12-24 | Baxter Biotech Technology S.A.R.L. | Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
DE10036491A1 (de) * | 2000-07-25 | 2002-02-07 | Roche Diagnostics Gmbh | Expression von Alkalischer Phosphatase in Hefe |
MXPA03008022A (es) | 2001-03-09 | 2003-12-04 | Genentech Inc | Proceso para la produccion de polipeptidos. |
US7504377B2 (en) | 2006-10-23 | 2009-03-17 | Ikor, Inc. | Nitric oxide-blocked cross-linked tetrameric hemoglobin |
US7494974B2 (en) | 2006-10-24 | 2009-02-24 | Ikor, Inc. | Carboxymethylated cross-linked tetrameric hemoglobin |
US20100204128A1 (en) * | 2007-07-24 | 2010-08-12 | Sanare Investment As | Novel peptides |
EP2058398A1 (en) * | 2007-11-09 | 2009-05-13 | Nipro Corporation | Production of recombinant human hemoglobin using pichia yeast |
KR101584540B1 (ko) * | 2014-04-16 | 2016-01-14 | 박병용 | 대형 식품용기 자동 세척장치 |
US10752672B1 (en) * | 2019-02-01 | 2020-08-25 | Cheer Global Limited | Recombinant hemoglobins and methods of preparation and use thereof |
US20230073947A1 (en) * | 2020-01-10 | 2023-03-09 | Intron Biotechnology, Inc. | A method for preparing bovine myoglobin using escherichia coli |
KR20220137895A (ko) * | 2020-01-10 | 2022-10-12 | 주식회사 인트론바이오테크놀로지 | 대장균을 사용한 돼지 미오글로빈의 제조 방법 |
CN116203144B (zh) * | 2022-05-11 | 2023-10-27 | 重庆医科大学附属儿童医院 | 测定血红蛋白中各型珠蛋白链比率的方法及其应用 |
CN118108834A (zh) * | 2022-11-30 | 2024-05-31 | 康码(上海)生物科技有限公司 | 重组血红蛋白 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3924943A (en) | 1974-06-11 | 1975-12-09 | Xerox Corp | Segmented biased transfer member |
US4769326A (en) | 1980-02-29 | 1988-09-06 | The Regents Of The University Of California | Expression linkers |
US4338397A (en) | 1980-04-11 | 1982-07-06 | President And Fellows Of Harvard College | Mature protein synthesis |
US4551433A (en) | 1981-05-18 | 1985-11-05 | Genentech, Inc. | Microbial hybrid promoters |
US4511503A (en) | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
US4599197A (en) | 1982-12-22 | 1986-07-08 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
US4512922A (en) | 1982-12-22 | 1985-04-23 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
US4620948A (en) | 1982-12-22 | 1986-11-04 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
GB8412517D0 (en) | 1984-05-16 | 1984-06-20 | Nagai K | Recombinant fusion proteins |
US4600531A (en) | 1984-06-27 | 1986-07-15 | University Of Iowa Research Foundation | Production of alpha-alpha cross-linked hemoglobins in high yield |
US4598064A (en) | 1984-06-27 | 1986-07-01 | University Of Iowa Research Foundation | Alpha-alpha cross-linked hemoglobins |
US4774180A (en) | 1986-02-26 | 1988-09-27 | Massachusetts Institute Of Technology | Construction and application of polyproteins |
US4704692A (en) | 1986-09-02 | 1987-11-03 | Ladner Robert C | Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides |
GB8701001D0 (en) | 1987-01-19 | 1987-02-18 | Gordon D G | Ceiling tiles |
WO1988006601A1 (en) | 1987-03-02 | 1988-09-07 | Genex Corporation | Gene repressors |
GB8711614D0 (en) * | 1987-05-16 | 1987-06-24 | Medical Res Council | Proteins |
EP0561245A1 (en) * | 1987-05-16 | 1993-09-22 | Somatogenetics International, Inc. | Blood substitutes comprising recombinant hemoglobin |
-
1990
- 1990-05-10 DE DE69034091T patent/DE69034091T2/de not_active Expired - Lifetime
- 1990-05-10 SG SG1996005941A patent/SG47987A1/en unknown
- 1990-05-10 AT AT90610036T patent/ATE142692T1/de active
- 1990-05-10 AU AU56756/90A patent/AU635744B2/en not_active Ceased
- 1990-05-10 EP EP03077231A patent/EP1380645A2/en not_active Withdrawn
- 1990-05-10 AT AT95110064T patent/ATE246246T1/de not_active IP Right Cessation
- 1990-05-10 NZ NZ233642A patent/NZ233642A/xx unknown
- 1990-05-10 ES ES95110064T patent/ES2204926T3/es not_active Expired - Lifetime
- 1990-05-10 WO PCT/US1990/002654 patent/WO1990013645A1/en active IP Right Grant
- 1990-05-10 DK DK90610036.7T patent/DK0402300T3/da active
- 1990-05-10 ES ES90610036T patent/ES2093640T3/es not_active Expired - Lifetime
- 1990-05-10 HU HU905111A patent/HUT61591A/hu unknown
- 1990-05-10 KR KR1019910701572A patent/KR920701434A/ko not_active Application Discontinuation
- 1990-05-10 IE IE19970086A patent/IE970086A1/en unknown
- 1990-05-10 DE DE69028448T patent/DE69028448T2/de not_active Expired - Fee Related
- 1990-05-10 CA CA002050601A patent/CA2050601C/en not_active Expired - Fee Related
- 1990-05-10 EP EP90610036A patent/EP0402300B1/en not_active Expired - Lifetime
- 1990-05-10 IL IL9436190A patent/IL94361A/en not_active IP Right Cessation
- 1990-05-10 EP EP95110064A patent/EP0700997B1/en not_active Expired - Lifetime
- 1990-05-10 JP JP2508220A patent/JP3013902B2/ja not_active Expired - Lifetime
-
1991
- 1991-11-08 NO NO914387A patent/NO304027B1/no not_active IP Right Cessation
- 1991-11-08 FI FI915279A patent/FI105104B/fi not_active IP Right Cessation
-
1996
- 1996-09-19 GR GR960402467T patent/GR3021106T3/el unknown
-
1997
- 1997-08-21 NO NO19973848A patent/NO315568B1/no not_active IP Right Cessation
-
2000
- 2000-01-05 FI FI20000025A patent/FI107938B/fi not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO914387D0 (no) | Fremstilling av hemoglobin og dens analoger i bakterier og gjaer | |
DE3650538D1 (de) | Interleukin-4 protein mit bcgf- und tcgf-aktivität gegenüber menschlichen zellen (menschliches interleukin-4) | |
ATE61407T1 (de) | Muteine biologisch aktiver proteine mit verringertem cysteingehalt, ihre herstellung, formulierungen, die solche muteine enthalten sowie strukturgene, vektoren und organismen, die zur herstellung der genannten muteine geeignet sind und deren herstellung. | |
DE3851225D1 (de) | Blutersatz. | |
NO177270C (no) | Fremg. for fremstilling av terapeutisk aktive, humane granulocytt-makrofag-"kolonistimulerende"-faktorproteiner (GM-CSF), bakteriell ekspresjonvektor som er i stand til å uttrykke GM-CSF samt bakteriecelle inneholdende vektoren | |
AU7681687A (en) | Expression of platelet-derived growth factor and analogues | |
DE68917061D1 (de) | O-glycosylierter IGF-1. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |